Skip to main content
Clinical Trials/NCT04923633
NCT04923633
Completed
Not Applicable

The Reproducibility and Consistency of Instrument-assisted Soft Tissue Manipulation

Indiana University1 site in 1 country106 target enrollmentMay 11, 2021
ConditionsMassage

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Massage
Sponsor
Indiana University
Enrollment
106
Locations
1
Primary Endpoint
Phase I Stroke Pattern Characteristic Descriptions
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The overall purpose of this study is to objectively describe and test the consistency and reproducibility of instrument-assisted soft tissue manipulation (IASTM).The specific aims of this current study are to:

  1. Analyze IASTM stroke patterns using objective metrics;
  2. Test the consistency of force application, with and without visual monitoring of objective metrics, and;
  3. Determine the reliability of dynamic pressure pain threshold assessment. The ultimate goal of this continuing line of research is to improve soft tissue manual therapy practice in research, education, and clinic for use as a non-invasive modality in soft tissue assessment and treatment. Results from this protocol will inform future clinical trials, including studies exploring the effects of different IASTM dose-loads in various musculoskeletal pain conditions.

Detailed Description

This is a single-site study consisting of three study phases. Phase I will observe and analyze clinician's application of instrument-assisted soft tissue manipulation (IASTM) as a means to identify signature profiles for the stroke rate, angle, and direction that are characteristic of basic (e.g., linear, curved) stroke patterns. Phase II will assess the consistency of IASTM force application. Phase III will assess the reliability of dynamic pressure pain threshold assessment. Clinician participants (Phase I) will attend one study visit consisting of basic linear and curved IASTM stroke pattern applications and complete a questionnaire. Total study duration for clinician participants will be 90 minutes. Non-clinician subjects will attend two study visits (Phase II) or one study visit (Phase III). Visits will consist of completion of questionnaires, application of IASTM strokes by a clinician using the QSTM device, and stretching.

Registry
clinicaltrials.gov
Start Date
May 11, 2021
End Date
October 19, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mary T. Loghmani

Associate Professor

Indiana University

Eligibility Criteria

Inclusion Criteria

  • Male or female between the ages of 18-75 years old.
  • Be a licensed, practicing healthcare clinician (e.g. physical therapist, massage therapist, osteopathic physician, athletic trainer, chiropractor)
  • Have at least 8 years of clinical experience in instrument-assisted soft tissue manual therapy
  • Male and female subjects between 18-75 years old
  • Body Mass Index (BMI) ≥ 18.5 kg/m2 but \<30 kg/m2
  • Male and female subjects, ages younger (≥18 but ≤30yo) and older (≥50 but ≤75yo)
  • Body Mass Index (BMI) ≥ 18.5 kg/m2 but \<30 kg/m2

Exclusion Criteria

  • \<8 years of clinical experience in instrument-assisted soft tissue manual therapy practice
  • Any known pain conditions, such as nerve impingement (radiculopathies), rheumatoid arthritis, osteoarthritis, or any other inflammatory conditions that could interfere with the participant's ability to perform basic IASTM stroke patterns.
  • Any known cardiovascular, pulmonary, or metabolic disease that could interfere with the clinician's ability to perform basic IASTM stroke patterns.
  • Known cardiovascular, pulmonary, or metabolic disease;
  • Current smoking or those who quit smoking within the previous 6 months;
  • Current use of anti-inflammatory or analgesics;
  • Any history of back, neck, lower extremity, or abdominal surgery or injury; or back, neck, or leg pain within the previous 6 months that impaired function;
  • Any co-morbidities that could contribute to back, neck, or leg pain (e.g., radiculopathies, rheumatoid arthritis, osteoarthritis, inflammatory conditions).
  • The same exclusion criteria as for Phase II.

Outcomes

Primary Outcomes

Phase I Stroke Pattern Characteristic Descriptions

Time Frame: Analysis results within 6 months.

The objectives metrics from quantifiable soft tissue manipulation device system will be analyzed for common or characteristic applications between clinicians.

Phase III Reliability of Dynamic Pressure Pain Threshold Assessment

Time Frame: Measured within 2 hours on same day of testing. Results reported by end of study at one year.

The agreement between and within clinicians in pressure pain threshold assessment over a body area will be determined within a single session.

Phase II Reliability of IASTM Force Application

Time Frame: Measured within 2 hours for same day reliability and at 7 days for between day reliability. Results reported by end of study at one year

The agreement in soft tissue manipulation force application, between and within clinicians, will be determined within a single session and between session (within 7 days apart).

Secondary Outcomes

  • (Phase III Only) Strength(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) Vertical Jump Test(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) Blood Pressure(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) Hamstring Length Flexibility Test.(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) Trunk Forward Bend Flexibility Test.(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) Static Pressure Pain Threshold(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) Range of Motion(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) Heart Rate(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) Skin Surface Temperature(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)
  • (Phase III Only) 10-Meter Walk Test (10-MWT)(Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.)

Study Sites (1)

Loading locations...

Similar Trials